Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Sr MD Chief Financial Officer | September 14, 2022 | September 19, 2022 |
| Marex Group LtdMRX · Entity 9106 | Director | June 09, 2026 | June 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date September 14, 2022 · Filed September 19, 2022 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 51,867 |
Reported balance
After 2022-09-14 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2022-09-14 · Tax withholding · Disposed 446 · Balance 51,867 F1: Mr. John Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2022. F2: This Form 4 is being amended to include the price at which shares were withheld for payment of taxes, which amount was inadvertently omitted from the original filing due to clerical error. |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. John Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2022.
F2: This Form 4 is being amended to include the price at which shares were withheld for payment of taxes, which amount was inadvertently omitted from the original filing due to clerical error.
Marex Group Ltd
Report date June 09, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 23,771 |
Reported balance
After 2026-06-09 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-09 · Grant · Acquired 2,070 · Balance 23,771 F1: The number of ordinary shares reported herein includes 2,070 shares underlying restricted share awards granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Filing footnotes · ownership attribution and instrument terms
F1: The number of ordinary shares reported herein includes 2,070 shares underlying restricted share awards granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2026 Filed Jun 11, 2026 20:05 UTC | Marex Group Ltd MRX · Entity 9106 | GrantOrdinary Shares | 2,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-267490 · ownership.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,771 F1 · balance_after: The number of ordinary shares reported herein includes 2,070 shares underlying restricted share awards granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 20:05 UTC | Marex Group Ltd MRX · Entity 9106 | Tax withholdingOrdinary Shares | 558 | $52.94 | $29,540.52 |
DisclosureSEC source: 0001193125-26-253463 · ownership.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,701 F1 · shares: Represents the number of ordinary shares withheld to satisfy the tax withholding obligation in connection with the vesting of certain previously reported shares underlying restricted share awards. F2 · price: The price reported represents the closing price of the Issuer's ordinary shares on the Nasdaq Stock Market LLC on May 29, 2026. Read SEC document |
| September 16, 2022 Filed Sep 19, 2022 22:28 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 387 | $191.56 | $74,133.72 |
DisclosureSEC source: 0001156375-22-000276 · wf-form4_166362642087325.xml · nonDerivative · entry 3 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,238 F2 · shares: Mr. John Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/2022. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 22:28 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 4,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-22-000276 · wf-form4_166362642087325.xml · nonDerivative · entry 2 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,625 Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 22:28 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 958 | $190.77 | $182,757.66 |
DisclosureSEC source: 0001156375-22-000276 · wf-form4_166362642087325.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,909 F1 · shares: Mr. John Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2022. Read SEC document |
| September 14, 2022 Filed Sep 15, 2022 21:50 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 446 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-22-000242 · wf-form4_166327860860629.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,867 F1 · shares: Mr. John Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2022. Read SEC document |
| September 14, 2022 Filed Sep 19, 2022 23:10 UTC Amendment | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 446 | $191.30 | $85,319.80 |
DisclosureSEC source: 0001156375-22-000296 · wf-form4a_166362903127689.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,867 F1 · shares: Mr. John Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2022. F2 · price: This Form 4 is being amended to include the price at which shares were withheld for payment of taxes, which amount was inadvertently omitted from the original filing due to clerical error. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:46 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,331 | $232.00 | $308,792.00 |
DisclosureSEC source: 0001156375-22-000137 · wf-form4_164754994022708.xml · nonDerivative · entry 2 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,313 F2 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:46 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 3,290 | $232.00 | $763,280.00 |
DisclosureSEC source: 0001156375-22-000137 · wf-form4_164754994022708.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,644 F1 · shares: Represents shares earned from a 2018 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2019-2021. Read SEC document |
| September 16, 2021 Filed Sep 17, 2021 19:28 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 407 | $188.69 | $76,796.83 |
DisclosureSEC source: 0001156375-21-000142 · wf-form4_163190687932341.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,354 F1 · shares: Mr. John Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/2021. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 16:54 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 4,368 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-21-000124 · wf-form4_163181127411995.xml · nonDerivative · entry 4 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,761 Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 16:54 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 522 | $188.96 | $98,637.12 |
DisclosureSEC source: 0001156375-21-000124 · wf-form4_163181127411995.xml · nonDerivative · entry 3 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,393 F2 · shares: Mr. John Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2021. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 16:54 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 537 | $188.96 | $101,471.52 |
DisclosureSEC source: 0001156375-21-000124 · wf-form4_163181127411995.xml · nonDerivative · entry 2 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,915 F2 · shares: Mr. John Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2021. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 16:54 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 470 | $188.85 | $88,759.50 |
DisclosureSEC source: 0001156375-21-000124 · wf-form4_163181127411995.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,452 F1 · shares: Mr. John Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2021. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 00:24 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 3,806 | $209.09 | $795,796.54 |
DisclosureSEC source: 0001156375-21-000034 · edgardoc.xml · nonDerivative · entry 2 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,922 F2 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 00:24 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 9,398 | $209.09 | $1,965,027.82 |
DisclosureSEC source: 0001156375-21-000034 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,728 F1 · shares: Represents shares earned from a 2017 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2018-2020. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 23:41 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $54.37 | $0.00 |
DisclosureSEC source: 0001156375-20-000125 · edgardoc.xml · derivative · entry 6 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 2,500 shares Expires 2021-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. F2 · derivative.exercise_date: As of 9/15/2015, this option vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 23:41 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $54.37 | $0.00 |
DisclosureSEC source: 0001156375-20-000125 · edgardoc.xml · derivative · entry 5 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock Class A · 2,500 shares Expires 2021-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. F2 · derivative.exercise_date: As of 9/15/2015, this option vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 23:41 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 2,500 | $180.00 | $450,000.00 |
DisclosureSEC source: 0001156375-20-000125 · edgardoc.xml · nonDerivative · entry 4 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,330 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 23:41 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionCommon Stock Class A | 2,500 | $54.37 | $135,925.00 |
DisclosureSEC source: 0001156375-20-000125 · edgardoc.xml · nonDerivative · entry 3 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 23:41 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 2,500 | $180.00 | $450,000.00 |
DisclosureSEC source: 0001156375-20-000125 · edgardoc.xml · nonDerivative · entry 2 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,330 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 23:41 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionCommon Stock Class A | 2,500 | $54.37 | $135,925.00 |
DisclosureSEC source: 0001156375-20-000125 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. Read SEC document |
| September 16, 2020 Filed Sep 17, 2020 22:01 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 423 | $170.20 | $71,994.60 |
DisclosureSEC source: 0001156375-20-000107 · edgardoc.xml · nonDerivative · entry 2 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,330 F1 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/2020. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 01:58 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 554 | $168.10 | $93,127.40 |
DisclosureSEC source: 0001156375-20-000100 · edgardoc.xml · nonDerivative · entry 3 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,845 F2 · shares: Mr. John William Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2020. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 01:58 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 569 | $168.10 | $95,648.90 |
DisclosureSEC source: 0001156375-20-000100 · edgardoc.xml · nonDerivative · entry 2 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,399 F2 · shares: Mr. John William Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2020. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 22:01 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 4,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000107 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,753 Read SEC document |
| September 14, 2020 Filed Sep 17, 2020 01:58 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 486 | $166.08 | $80,714.88 |
DisclosureSEC source: 0001156375-20-000100 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,968 F1 · shares: Mr. John William Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2020. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:39 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 2,736 | $182.01 | $497,979.36 |
DisclosureSEC source: 0001156375-20-000025 · edgardoc.xml · nonDerivative · entry 4 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,102 F2 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:39 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 6,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000025 · edgardoc.xml · nonDerivative · entry 3 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,838 F1 · shares: Represents shares earned from a 2016 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2017-2019. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:39 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 2,329 | $182.01 | $423,901.29 |
DisclosureSEC source: 0001156375-20-000025 · edgardoc.xml · nonDerivative · entry 2 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,662 F2 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:39 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 6,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000025 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,991 F1 · shares: Represents shares earned from a 2016 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2017-2019. Read SEC document |
| March 15, 2020 Filed Jun 11, 2020 14:01 UTC Amendment | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 6,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000047 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,454 F1 · shares: Represents shares earned from a 2016 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2017-2019. F2 · balance_after: The original Form 4 filed on 03/15/2020 incorrectly reported the transaction as a disposition. This amendment is being filed to correctly report the transaction as an acquisition and correct filer's beneficial ownership. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 22:33 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 3,984 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000101 · edgardoc.xml · nonDerivative · entry 5 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,167 Read SEC document |
| September 15, 2019 Filed Sep 17, 2019 22:33 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 591 | $205.80 | $121,627.80 |
DisclosureSEC source: 0001156375-19-000101 · edgardoc.xml · nonDerivative · entry 4 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,183 F2 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2019. Read SEC document |
| September 15, 2019 Filed Sep 17, 2019 22:33 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 614 | $205.80 | $126,361.20 |
DisclosureSEC source: 0001156375-19-000101 · edgardoc.xml · nonDerivative · entry 3 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,774 F2 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2019. Read SEC document |
| September 15, 2019 Filed Sep 17, 2019 22:33 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 453 | $205.80 | $93,227.40 |
DisclosureSEC source: 0001156375-19-000101 · edgardoc.xml · nonDerivative · entry 2 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,388 F2 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2019. Read SEC document |
| September 14, 2019 Filed Sep 17, 2019 22:33 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 513 | $205.80 | $105,575.40 |
DisclosureSEC source: 0001156375-19-000101 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,841 F1 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2019. Read SEC document |
| September 04, 2019 Filed Sep 6, 2019 13:05 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 2,500 | $217.62 | $544,050.00 |
DisclosureSEC source: 0001156375-19-000093 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,354 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. Read SEC document |
| July 09, 2019 Filed Jul 11, 2019 19:55 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 2,500 | $201.30 | $503,250.00 |
DisclosureSEC source: 0001156375-19-000079 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,854 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. Read SEC document |
| April 03, 2019 Filed Apr 4, 2019 16:42 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 2,500 | $168.27 | $420,675.00 |
DisclosureSEC source: 0001156375-19-000029 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,354 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. Read SEC document |
| March 16, 2019 Filed Mar 20, 2019 00:36 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 128 | $170.14 | $21,777.92 |
DisclosureSEC source: 0001156375-19-000024 · edgardoc.xml · nonDerivative · entry 5 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,854 F3 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/16/19. Read SEC document |
| March 15, 2019 Filed Mar 20, 2019 00:36 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 2,093 | $170.14 | $356,103.02 |
DisclosureSEC source: 0001156375-19-000024 · edgardoc.xml · nonDerivative · entry 4 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,982 F2 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2019 Filed Mar 20, 2019 00:36 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 4,724 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000024 · edgardoc.xml · nonDerivative · entry 3 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,075 F1 · shares: Represents shares earned from a 2015 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2016-2018. Read SEC document |
| March 15, 2019 Filed Mar 20, 2019 00:36 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 2,093 | $170.14 | $356,103.02 |
DisclosureSEC source: 0001156375-19-000024 · edgardoc.xml · nonDerivative · entry 2 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,351 F2 · shares: Mr. Pietrowicz surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2019 Filed Mar 20, 2019 00:36 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 4,724 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000024 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,444 F1 · shares: Represents shares earned from a 2015 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2016-2018. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:46 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,740 | $0.00 Strike: $62.83 | $0.00 |
DisclosureSEC source: 0001156375-19-000001 · edgardoc.xml · derivative · entry 9 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 1,740 shares Expires 2020-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: As of 3/15/2014, this option vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:46 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,160 | $0.00 Strike: $56.87 | $0.00 |
DisclosureSEC source: 0001156375-19-000001 · edgardoc.xml · derivative · entry 8 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 4,160 shares Expires 2019-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: As of 9/15/2013, this option vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:46 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 12,060 | $0.00 Strike: $54.30 | $0.00 |
DisclosureSEC source: 0001156375-19-000001 · edgardoc.xml · derivative · entry 7 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 12,060 shares Expires 2020-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: As of 9/15/2014, this option vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:46 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 4,160 | $186.98 | $777,834.72 |
DisclosureSEC source: 0001156375-19-000001 · edgardoc.xml · nonDerivative · entry 6 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,720 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. F3 · price: On January 2, 2019, Mr. Pietrowicz sold an aggregate of 4,160 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $186.25 to $186.97 and $187.00 to $187.65. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:46 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionCommon Stock Class A | 4,160 | $56.87 | $236,579.20 |
DisclosureSEC source: 0001156375-19-000001 · edgardoc.xml · nonDerivative · entry 5 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.